- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: JNJ-40346527/Placebo
Total 54433 results
-
Johnson & Johnson Pharmaceutical Research & Development...Completed
-
Janssen Research & Development, LLCRecruitingMyasthenia GravisUnited States, Japan, Netherlands, Poland
-
Janssen Research & Development, LLCBristol-Myers SquibbCompleted
-
Janssen Research & Development, LLCActive, not recruitingUrothelial CarcinomaFrance, United States, Korea, Republic of, Belgium, Poland, Taiwan, Turkey, Russian Federation, Spain, Italy, United Kingdom, Brazil, Belarus
-
Johnson & Johnson Pharmaceutical Research & Development...Completed
-
Janssen Research & Development, LLCCompleted
-
Janssen Research & Development, LLCCompletedDepressive Disorder, MajorGermany, Netherlands
-
Janssen Research & Development, LLCActive, not recruitingSystemic Lupus ErythematosusJapan, Taiwan, Spain, United States, Argentina, Ukraine, Germany, Hungary, Poland, Bulgaria, Colombia, South Africa
-
CCTU-CoreJanssen PharmaceuticalsActive, not recruitingInflammation | Depressive Disorder, MajorUnited Kingdom
-
Johnson & Johnson Pharmaceutical Research & Development...CompletedHistamine Induced ItchUnited Kingdom
-
Janssen Research & Development, LLCThe George Institute for Global Health, AustraliaCompletedCardiovascular Diseases | Diabetes Mellitus, Type 2 | Risk FactorsUnited States, Australia, Poland, Ukraine, United Kingdom, Belgium, Germany, France, Spain, Argentina, Colombia, Israel, Mexico, India, Canada, Netherlands, Sweden, Malaysia, New Zealand, Estonia, Russian Federation, Hungary, Norway, ... and more
-
Janssen Research & Development, LLCCompleted
-
Janssen Research & Development, LLCCompletedColitis, UlcerativeUnited States, Australia, France, Ukraine, Germany, Israel, Poland, Bulgaria, Romania, Russian Federation, Canada, Netherlands, Belgium, Hungary
-
Janssen Research & Development, LLCCompleted
-
Janssen Vaccines & Prevention B.V.Completed
-
Janssen Pharmaceutical K.K.Completed
-
Johnson & Johnson Enterprise Innovation Inc.RecruitingCarcinoma, Non-small-Cell LungKorea, Republic of, Spain, United States, Germany
-
Janssen Research & Development, LLCCompleted
-
Janssen Pharmaceutica N.V., BelgiumCompleted
-
NRG OncologyNational Cancer Institute (NCI)Active, not recruitingPSA Progression | Stage III Prostate Adenocarcinoma | Stage IV Prostate AdenocarcinomaUnited States, Canada
-
Janssen Research & Development, LLCCompletedPhobic DisordersUnited States, Australia, Canada
-
Janssen Research & Development, LLCNot yet recruitingLupus NephritisUnited States
-
Johnson & Johnson Pharmaceutical Research & Development...CompletedDiabetes Mellitus, Type 2
-
Janssen Research & Development, LLCActive, not recruitingHepatitis B, ChronicFrance, Belgium, Italy, United Kingdom, Poland, Spain, New Zealand, Taiwan
-
Janssen Research & Development, LLCRecruitingCarcinoma, Non-Small-Cell LungKorea, Republic of, United States, Malaysia, Turkey
-
Janssen Research & Development, LLCCompleted
-
Janssen Research & Development, LLCRecruitingRelapsed or Refractory Multiple Myeloma | Previously Treated Amyloid Light-chain (AL) AmyloidosisBelgium, United States, United Kingdom, Spain, France, Netherlands
-
Janssen Research & Development, LLCRecruitingLymphoma, Non-Hodgkin | Leukemia, Lymphocytic, Chronic, B-CellUnited States, China, France, Denmark, Israel, Poland, Australia
-
Janssen Research & Development, LLCCompletedMyelodysplastic Syndromes | Leukemia, Myeloid, AcuteUnited States, Spain, Germany
-
Janssen Research & Development, LLCCompleted
-
Janssen Research & Development, LLCCompleted
-
Janssen Research & Development, LLCCompleted
-
Johnson & Johnson Pharmaceutical Research & Development...Completed
-
Janssen Research & Development, LLCCompleted
-
Janssen Research & Development, LLCRecruiting
-
Janssen Research & Development, LLCRecruitingNeoplasms | Myeloproliferative Disorders | Essential Thrombocythemia | MyelofibrosisUnited States, Spain, France, Canada
-
Merck Sharp & Dohme LLCRecruitingHepatic Impairment | Non-alcoholic SteatohepatitisUnited States
-
Janssen Research & Development, LLCActive, not recruitingLymphoma, Non-Hodgkin | Leukemia, Lymphocytic, Chronic, B-CellUnited States, Korea, Republic of, United Kingdom, Taiwan, Israel, Spain, Australia, France
-
Janssen Vaccines & Prevention B.V.Completed
-
Janssen Scientific Affairs, LLCAvailable
-
Janssen Vaccines & Prevention B.V.Completed
-
Janssen Research & Development, LLCCompleted
-
Janssen Pharmaceutical K.K.CompletedProstatic Neoplasms, Castration-ResistantJapan
-
Janssen Research & Development, LLCTerminatedAdvanced CancerUnited States
-
Johnson & Johnson Pharmaceutical Research & Development...TerminatedMyelodysplastic Syndromes | Advanced or Refractory LeukemiaUnited States
-
Johnson & Johnson Pharmaceutical Research & Development...Janssen Pharmaceutica N.V., BelgiumCompletedPharmacokinetics | Advanced Malignancies | Solid Malignancies | Protein Kinase Inhibitors | Maximum Tolerated Dose | Antineoplastic Protocols | Clinical Trial, Phase 1
-
Janssen Research & Development, LLCCompletedDepressive Disorder, Treatment-ResistantUnited States
-
Janssen Research & Development, LLCTerminatedHidradenitis SuppurativaUnited States, Germany, Canada, Japan, Netherlands, Spain, Australia, Poland
-
Janssen Research & Development, LLCCompletedAlzheimer DiseaseUnited States
-
Janssen Vaccines & Prevention B.V.CompletedRespiratory Tract Infections | Respiratory Syncytial VirusesUnited Kingdom, Finland, United States